We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
S100A13 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
236.9
Number of samples
349
Samples
Sample
Description
TPM
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
1247.9
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
1232.9
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
1149.4
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
856.1
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
831.8
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
753.4
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
737.0
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
733.0
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
688.9
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
680.2
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
628.6
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
628.4
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
599.2
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
572.2
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
568.0
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
559.0
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
539.9
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
487.4
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
481.6
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
480.5
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
477.8
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
473.4
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
470.8
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
459.3
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
454.3
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
453.0
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
452.8
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
452.3
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
450.9
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
449.5
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
448.1
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
443.7
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
440.3
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
436.2
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
433.6
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
426.2
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
414.9
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
411.3
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
402.0
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
401.1
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
392.3
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
388.9
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
388.0
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
386.8
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
382.6
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
376.0
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
372.8
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
370.6
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
362.3
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
356.1
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
354.2
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
349.8
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
346.4
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
346.1
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
345.8
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
345.7
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
345.7
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
344.6
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
344.0
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
339.9
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
337.5
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
337.2
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
332.8
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
331.3
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
330.8
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
328.3
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
327.5
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
326.2
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
326.0
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
323.3
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
322.3
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
321.8
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
321.3
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
318.9
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
312.2
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
307.5
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
306.6
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
305.9
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
304.2
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
302.9
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
300.4
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
300.1
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
298.7
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
297.1
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
295.9
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
293.4
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
290.2
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
289.3
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
288.6
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
283.4
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
282.5
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
279.8
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
279.8
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
278.7
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
277.9
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
277.5
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
276.7
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
276.6
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
276.2
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
273.4
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
270.7
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
267.3
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
264.4
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
264.1
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
264.0
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
263.9
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
262.7
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
262.6
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
261.0
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
257.7
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
256.1
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
255.2
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
254.1
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
252.1
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
250.2
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
248.2
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
246.1
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
245.7
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
245.5
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
245.2
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
244.4
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
242.0
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
241.8
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
241.7
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
241.1
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
239.4
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
237.7
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
236.9
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
236.0
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
233.4
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
231.5
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
231.0
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
230.8
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
230.6
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
229.7
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
229.1
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
229.0
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
227.1
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
226.9
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
226.0
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
225.4
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
225.1
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
223.0
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
222.1
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
220.3
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
219.5
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
218.0
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
217.1
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
216.5
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
215.2
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
214.8
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
214.7
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
213.6
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
212.8
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
212.6
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
212.0
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
211.3
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
210.7
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
210.5
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
210.4
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
210.2
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
209.5
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
207.8
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
206.7
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
204.9
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
204.8
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
204.5
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
204.3
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
204.3
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
201.9
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
201.7
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
200.1
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
197.7
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
197.2
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
196.8
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
196.2
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
195.4
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
195.3
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
194.5
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
194.1
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
193.1
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
193.0
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
192.1
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
191.8
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
191.4
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
191.3
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
191.2
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
191.0
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
190.7
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
189.8
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
188.3
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
187.0
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
186.0
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
185.9
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
185.4
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
185.1
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
184.8
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
184.6
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
184.6
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
183.3
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
183.0
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
181.3
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
181.2
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
180.9
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
180.1
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
179.3
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
178.7
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
178.6
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
177.0
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
173.4
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
172.6
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
171.3
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
170.4
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
169.6
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
168.4
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
167.3
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
167.0
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
166.6
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
166.4
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
166.3
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
165.3
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
162.9
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
161.6
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
161.4
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
158.5
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
158.5
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
158.4
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
157.1
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
156.7
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
156.3
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
155.7
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
153.6
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
152.6
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
150.6
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
150.3
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
150.2
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
149.5
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
148.1
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
147.5
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
146.5
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
146.2
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
145.2
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
143.0
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
142.6
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
142.4
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
142.3
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
140.1
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
139.9
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
139.8
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
139.2
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
139.1
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
138.5
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
137.7
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
136.3
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
135.8
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
134.7
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
134.6
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
134.1
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
132.5
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
130.7
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
130.2
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
129.5
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
129.2
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
129.1
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
129.0
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
128.5
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
128.0
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
127.4
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
127.0
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
126.7
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
124.5
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
124.4
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
124.3
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
124.0
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
123.1
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
122.5
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
122.3
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
121.4
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
121.4
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
120.2
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
120.2
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
118.9
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
116.8
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
115.4
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
115.1
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
115.0
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
111.9
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
111.7
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
111.6
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
111.5
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
111.3
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
111.2
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
109.9
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
108.9
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
108.8
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
108.5
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
108.1
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
107.8
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
107.5
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
106.7
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
105.2
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
104.2
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
103.8
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
103.3
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
101.9
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
101.8
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
100.8
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
100.3
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
100.0
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
99.5
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
98.6
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
98.2
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
96.7
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
96.0
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
95.1
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
95.0
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
94.8
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
94.1
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
92.6
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
92.2
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
90.7
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
88.9
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
84.1
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
81.9
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
81.7
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
79.1
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
79.1
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
78.5
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
77.2
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
72.7
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
68.6
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
68.1
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
67.9
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
67.6
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
66.7
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
66.6
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
65.4
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
63.5
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
62.8
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
61.6
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
61.4
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
61.3
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
61.1
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
60.0
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
57.2
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
53.9
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
51.5
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
49.6
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
S100A13 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
476.3
Number of samples
81
Samples
Sample
Description
TPM
DO46611
0 years, female, NA, stage:III, dead, 734 days
3021.9
DO46366
0 years, female, NA, stage:III, dead, 2054 days
2399.5
DO46581
0 years, female, NA, stage:III, dead, 408 days
1413.5
DO46342
0 years, female, NA, stage:III, dead, 1398 days
1263.8
DO46390
0 years, female, NA, stage:III, dead, 374 days
1128.1
DO46388
0 years, female, NA, stage:III, dead, 413 days
1111.6
DO46380
0 years, female, NA, stage:III, dead, 1423 days
1095.6
DO46333
0 years, female, NA, stage:III, dead, 359 days
961.1
DO46350
0 years, female, NA, stage:III, dead, 886 days
960.8
DO46576
0 years, female, NA, stage:III, alive, 133 days
809.4
DO46356
0 years, female, NA, stage:III, dead, 911 days
786.8
DO46370
0 years, female, NA, stage:III, dead, 1727 days
687.7
DO46400
0 years, female, NA, stage:III, dead, 719 days
683.0
DO46412
0 years, female, NA, stage:III, dead, 597 days
655.3
DO46374
0 years, female, NA, stage:III, dead, 1409 days
647.0
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
645.5
DO46372
0 years, female, NA, stage:III, dead, 1326 days
639.6
DO46551
0 years, female, NA, stage:III, dead, 1055 days
617.3
DO46463
0 years, female, NA, stage:III, dead, 2451 days
565.2
DO46346
0 years, female, NA, stage:III, dead, 1187 days
557.0
DO46352
0 years, female, NA, stage:III, dead, 677 days
548.7
DO46448
0 years, female, NA, stage:III, dead, 654 days
530.3
DO46330
0 years, female, NA, stage:III, dead, 684 days
508.6
DO46591
0 years, female, NA, stage:III, dead, 195 days
488.7
DO46354
0 years, female, NA, stage:III, dead, 843 days
480.9
DO46368
0 years, female, NA, stage:III, dead, 2879 days
479.5
DO46538
0 years, female, NA, stage:III, dead, 1527 days
471.9
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
469.9
DO46571
0 years, female, NA, stage:III, dead, 243 days
449.3
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
440.9
DO46568
0 years, female, NA, stage:III, dead, 320 days
431.5
DO46327
0 years, female, NA, stage:III, dead, 184 days
406.1
DO46364
0 years, female, NA, stage:III, dead, 806 days
400.9
DO46561
0 years, female, NA, stage:III, dead, 195 days
364.9
DO46376
0 years, female, NA, stage:III, dead, 1430 days
356.7
DO46402
0 years, female, NA, stage:III, dead, 511 days
349.5
DO46396
0 years, female, NA, stage:III, dead, 583 days
335.1
DO46382
0 years, female, NA, stage:IV, dead, 311 days
331.0
DO46358
0 years, female, NA, stage:III, dead, 423 days
325.2
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
323.8
DO46378
0 years, female, NA, stage:III, alive, 843 days
309.7
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
307.2
DO46493
0 years, female, NA, stage:IV, alive, 839 days
301.2
DO46336
0 years, female, NA, stage:IV, dead, 664 days
300.9
DO46508
0 years, female, NA, stage:III, dead, 2101 days
292.2
DO46398
0 years, female, NA, stage:III, alive, 437 days
286.0
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
283.1
DO46533
0 years, female, NA, stage:III, alive, 3667 days
279.1
DO46331
0 years, female, NA, stage:III, dead, 612 days
269.2
DO46404
0 years, female, NA, stage:III, dead, 690 days
267.2
DO46453
0 years, female, NA, stage:III, dead, 3294 days
267.0
DO46546
0 years, female, NA, stage:III, dead, 1889 days
266.8
DO46334
0 years, female, NA, stage:III, dead, 496 days
266.2
DO46606
0 years, female, NA, stage:III, alive, 804 days
262.4
DO46560
0 years, female, NA, stage:IV, dead, 286 days
259.4
DO46392
0 years, female, NA, stage:III, dead, 628 days
258.4
DO46386
0 years, female, NA, stage:III, dead, 1162 days
244.4
DO46384
0 years, female, NA, stage:III, dead, 614 days
243.2
DO46344
0 years, female, NA, stage:III, dead, 642 days
242.8
DO46518
0 years, female, NA, stage:III, alive, 2960 days
239.7
DO46432
0 years, female, NA, stage:III, alive, 2218 days
239.4
DO46329
0 years, female, NA, stage:III, dead, 1699 days
238.6
DO46325
0 years, female, NA, stage:III, dead, 477 days
235.5
DO46566
0 years, female, NA, stage:III, dead, 673 days
233.9
DO46528
0 years, female, NA, stage:III, alive, 6139 days
233.6
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
226.5
DO46326
0 years, female, NA, stage:III, dead, 701 days
225.3
DO46443
0 years, female, NA, stage:III, dead, 2464 days
221.8
DO46408
0 years, female, NA, stage:III, dead, 489 days
212.4
DO46597
0 years, female, NA, stage:III, dead, 393 days
197.9
DO46348
0 years, female, NA, stage:IV, dead, 287 days
183.4
DO46362
0 years, female, NA, stage:III, dead, 1639 days
178.0
DO46328
0 years, female, NA, stage:III, dead, 972 days
177.7
DO46338
0 years, female, NA, stage:III, dead, 596 days
174.8
DO46340
0 years, female, NA, stage:III, dead, 616 days
170.6
DO46332
0 years, female, NA, stage:III, dead, 689 days
168.8
DO46436
0 years, female, NA, stage:III, alive, 3193 days
160.2
DO46586
0 years, female, NA, stage:III, dead, 1019 days
159.8
DO46588
0 years, female, NA, stage:III, dead, 438 days
159.2
DO46468
0 years, female, NA, stage:III, alive, 2776 days
114.9
DO46602
0 years, female, NA, stage:III, dead, 205 days
80.0
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
1.7
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
1.6
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
1.6
285fed94-1495-448e-879b-b55de9_D2
Tumor
1.4
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
1.4
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
1.3
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
1.3
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
1.3
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
1.2
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
1.2
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
1.1
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
1.0
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
1.0
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
1.0
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.9
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.9
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.8
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.8
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.8
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.7
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.7
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.6
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.6
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.6
1db5574d-aca7-403c-8100-6e705f_D2
Normal
0.5
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.5
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.5
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.5
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.5
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.4
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.4
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.4
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.4
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.4
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.4
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.4
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.3
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.3
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.3
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.3
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.3
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.3
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.3
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.3
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.2
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.2
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.2
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.2
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.2
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.2
15524912-685a-47ce-a824-567848_D2
Tumor
0.2
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.2
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.2
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.2
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.2
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.1
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.1
21efd60f-6a31-4b98-9477-16a905_D2
Normal
0.1
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.1
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.1
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.1
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.0
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.0
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.0
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.0
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.0
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-0.1
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.1
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.1
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.2
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.2
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.2
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.2
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.2
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.2
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.2
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.2
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.2
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.2
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
-0.2
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.3
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.3
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.3
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.3
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.3
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.3
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.3
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.3
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
-0.4
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
-0.4
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-0.4
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.5
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.5
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.5
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.5
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.5
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-0.6
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.7
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.7
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
-0.7
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.7
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.7
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
-0.7
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.8
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.8
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.9
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-1.1
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-1.5
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.